Vinge advises Scania on its acquisition of Northvolt’s Systems Industrial business, including production capabilities, a research and development center, and a team of approximately 260 employees. The operations are based in two locations: a production facility in Gdańsk, Poland, and an R&D center in Tomteboda, Stockholm, Sweden.

Northvolt’s Systems Industrial division develops and manufactures battery systems for heavy industry and off-highway market segments, offering a portfolio of battery modules and systems used in material handling, construction equipment, and mining. The acquired business will be a partner to Scania Power Solutions and be operated as a stand-alone venture within Scania Ventures and New Business, aligning with Scania’s strategy to develop complementary and transformational businesses that strengthen Scania’s long-term competitiveness.

With over a century of powertrain innovation, Scania Power Solutions has built a strong reputation for delivering reliable and efficient engines that meet the toughest demands in the industrial, marine, and power generation segments. With this acquisition Scania will strengthen its electrification offering for off-road applications.

Vinge's team consisted of lawyers from all of Vinge’s offices in Stockholm, Gothenburg, Malmö and Brussels. The team was headed by Jonas Johansson and Linus Adolfsson (M&A) and in addition thereto primarily consisted of Henrik Borna, Desirée Hagenfeldt, Jonatan Karlsson, Sara Hammond (Corporate och M&A), Morgan Hallén, Petronella Hallberg, Malin Olsson (Restructuring and Insolvency), Sebastian Örndahl, Martin Johansson, Dagne Sabockis, Hilda Ivarsson (EU, Competition and Regulatory), Malin Malm Waerme, Arvid Axelryd, (Intellectual Property), Eva Fredrikson, Anna Jonsson, Nicklas Thorgezon (Corporate Commercial), Simon Söderholm (Employment), Niclas Winnberg, Anna Edström and Simon Gille-Johnson (Real Estate).

 

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026